NCT07509853 Integrating Sexual Pleasure Into Harm Reduction Services for Men Who Have Sex With Men and Transgender Persons Who Engage in Chemsex or Substance Use in Thailand
| NCT ID | NCT07509853 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institute of HIV Research and Innovation Foundation, Thailand |
| Condition | HIV Prevention |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2025-05-01 |
| Primary Completion | 2027-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2025-05-01 with a primary completion date of 2027-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study evaluates the integration of a sexual pleasure-based approach into harm reduction services for MSM and transgender persons engaging in chemsex or substance use in Thailand, using the "Pleasuremeter" tool to improve sexual health and related outcomes.
Eligibility Criteria
Inclusion Criteria: * MSM, transgender women, transgender men, or non-binary persons * Age ≥18 years * Engaged in chemsex or substance use within past 12 months * Able to provide informed consent Exclusion Criteria: • Unable to communicate in Thai sufficiently to complete study procedures
Contact & Investigator
Akarin Hiransuthikul, MD,MSc
PRINCIPAL INVESTIGATOR
Chulalongkorn University
Frequently Asked Questions
Who can join the NCT07509853 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying HIV Prevention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07509853 currently recruiting?
Yes, NCT07509853 is actively recruiting participants. Contact the research team at nittaya.p@ihri.org for enrollment information.
Where is the NCT07509853 trial being conducted?
This trial is being conducted at Pathum Wan, Thailand.
Who is sponsoring the NCT07509853 clinical trial?
NCT07509853 is sponsored by Institute of HIV Research and Innovation Foundation, Thailand. The principal investigator is Akarin Hiransuthikul, MD,MSc at Chulalongkorn University. The trial plans to enroll 300 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.